2 days 22 hours ago
Ontario listed SGLT-2 inhibitors (SGLT2i) as regular public drug benefits for adults age ≥ 65, while other Canadian provinces providing benefits for SGLT2i implemented special authorization restrictions. We hypothesized that special authorization led to lower SGLT2i use among older adults with diabetes and cardiovascular disease (CVD) in other provinces (Alberta, Manitoba, New Brunswick, and Saskatchewan), compared to Ontario.
Darren Lau, Douglas C. Dover, Hena Qureshi, Roseanne O. Yeung, Dean Eurich, Peter Senior, Sonia Butalia, Padma Kaul
2 days 22 hours ago
To assess the feasibility and acceptability of a patient navigator (PN) in a pediatric type 1 diabetes (T1D) clinic.
Elise Schlissel Tremblay, Ashley B. Tartarilla, Kali McCollister, Mia Umali, Melicia Y. Whitley, Julia Ainsworth, Patrice Melvin, Lori M. Laffel, Valerie L. Ward
2 days 22 hours ago
Adolescents and young adults (AYA) often report feeling poorly prepared and dissatisfied with the process of transitioning from pediatric to adult type 1 diabetes (T1D) care. We aimed to examine the impact of Bridging the Gap (BTG), an audit and feedback-based intervention, on transition care.
Syed Zain Ahmad, Noah Ivers, Ian Zenlea, Baiju R. Shah, Peter C. Austin, Cheril Clarson, Jennifer Harrington, Alanna Landry, Geetha Mukerji, Zubin Punthakee, Mark R. Palmert, Janet Parsons, Mikayla Sonnenberg, Rayzel Shulman
1 week 3 days ago
Angela Y. Kim, James Hanley, Rebecca Fuhrer, Charles de Mestral
1 week 3 days ago
Syed Aaraiz Ul Hassan, Krishna Jaipal Lohana, Shorrem Naeem
1 week 3 days ago
To compare severe hypoglycemia and all-cause mortality between insulin regimens in people with type 2 diabetes on insulin.
Reid H. Whitlock, Zach Raizman, David Collister, Katherine J. Bernier, Sarah M. Sigurdson, Navdeep Tangri, Clara Bohm, Claudio Rigatto, Paul Komenda, Jennifer M. Yamamoto
2 weeks 1 day ago
We investigated hypertension control (<130/80 mmHg) among individuals with diabetes, use of first-line antihypertensive medications, and physician responses to uncontrolled blood pressure (BP) measurements (i.e. repeat measurements and medication intensification).
Sachin V. Pasricha, Lisa Dubrofsky, Bailey Goldman, Laura O’Driscoll, Huijuan Yang, Shane Golden, Brad Millson, Sheldon W. Tobe
2 weeks 3 days ago
Syed Aaraiz Ul Hassan, Noor Ul Huda, Noor Un Nisa
2 weeks 5 days ago
Syeda Kashaf Batool, Fatima Asif, Muhammad Owais
2 weeks 5 days ago
Muhammad Husnain Ahmad, Muhammad Bilal, Muhammad Ibrahim, Hafiza Iman
2 weeks 5 days ago
the article by Dolatabadi et al. offers timely insights into the use of virtual care in managing gestational diabetes mellitus (GDM), but several critical limitations temper the strength and applicability of its conclusions. This Letter to the Editor outlines concerns regarding the study’s retrospective design, its omission of patient-reported and adherence-related outcomes, and its limited generalizability. Drawing on recent literature, including evaluations aligned with the Quadruple Aim and meta-analyses of digital interventions, we argue for more robust and patient-centered methodologies in future research.
Muhammad Khubaib Iftikhar
3 weeks 3 days ago
Rongrong Chen, Lin Sheng, Xiaohan Zhang
3 weeks 3 days ago
Unstable housing and homelessness are associated with increased risks of diabetes-related morbidity and mortality. Concordantly, as few as 12-30% of people with lived experience of homelessness (PWLEH) complete recommended screening for microvascular complications of diabetes. Innovative models of care delivery are needed to address this disparity. We recently piloted a novel, community-based, point-of-care screening program for diabetes complications (the SAFER model of care, i.e. Screening for glycosylated hemoglobin (A1c), feet, eyes and renal function) in Calgary, Alberta.
Hannah M. Yaphe, Sara Scott, Huanghe Ding, Breanna McSweeney, Eshleen Grewal, David JT. Campbell
1 month 2 weeks ago
The publisher regrets that Supplementary Material failed to be published with this article and is now included. The publisher apologizes for any inconvenience caused.
Ilana J. Halperin, Brandy Wicklow, Shazhan Amed, Alanna Chambers, Charlotte Courage, Elizabeth Cummings, Patricia Kirkland, Dylan MacKay, Meranda Nakhla, Zubin Punthakee, Paul M. Ryan, Lindsay Sawatsky, Peter A. Senior, Bikrampal S. Sidhu, Alanna Weisman…
1 month 2 weeks ago
Insomnia a condition marked by difficulty initiating or maintaining sleep, or early morning awakenings despite an adequate opportunity for adequate rest. It affects up to one-third of adults, with around 10% meeting the criteria for insomnia disorder. Emerging research increasingly points to insomnia as a significant, modifiable risk factor for cardiometabolic diseases, including type 2 diabetes, cardiovascular disease, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease (MASLD).
J.W. Kim, A.B. Jain, A. Khullar
1 month 2 weeks ago
Noor Ul Huda, Muhammad Raza, Maryam Maheen
1 month 2 weeks ago
The rising prevalence of gestational diabetes (GDM) presents a challenge to healthcare systems. Virtual care has emerged as a potential solution to alleviate this burden, but limited data exist on its effectiveness. This study evaluated maternal and neonatal outcomes in individuals with GDM managed with virtual care versus in-person care.
Samin Dolatabadi, Jennifer M. Yamamoto, Erin A. Brennand, Lois E. Donovan, Jamie L. Benham
1 month 3 weeks ago
Gestational diabetes mellitus (GDM) increases future risks of type 2 diabetes and cardiovascular disease. Despite Diabetes Canada guidelines recommending postpartum glucose testing following GDM, uptake remains low. Canadian population-based studies are needed to examine systems-level factors affecting uptake.
Kathleen Baker, Nikki Stephenson, Colleen Cuthbert, Doreen Rabi, Amy Metcalfe
1 month 3 weeks ago
This study explores the link between circulating vitamin C levels and the risk of diabetes mellitus (DM) using data from the National Health and Nutrition Examination Survey (NHANES) for the cycles of 2003-2004, 2005-2006, and 2017-2018. Our analysis revealed a significant inverse relationship, showing that higher levels of vitamin C are associated with a reduced risk of DM. Specifically, higher vitamin C concentrations correlated with lower odds of DM, particularly at elevated quartile levels. Despite these findings, Mendelian randomization (MR) analysis did not establish a causal link between vitamin C and type 1 diabetes (T1DM).
Zhitong Li, Jinchang Liu, Xingyu Li, Shiwei Liu
2 months ago
People with diabetes are vulnerable to health inequities and population level COVID-19 vaccine uptake among adults with diabetes is unknown. Our aim was to assess COVID-19 vaccine uptake among adults with and without diabetes and the factors associated with vaccination.
Sonia Butalia, Ronald J. Sigal, Baiju R. Shah, Jamie L. Benham, Brandy Wicklow, Catherine H. Yu, Kaberi Dasgupta, Luan M. Chu, Shazhan Amed, Cora Constantinescu, Padma Kaul
Checked
2 hours 44 minutes ago
Canadian Journal of Diabetes RSS feed.
Subscribe to Canadian Journal of Diabetes feed
